0
ARTICLE |

BACITRACIN

Frank L. Meleney, M.D.
AMA Arch Intern Med. 1953;91(3):414. doi:10.1001/archinte.1953.00240150133013.
Text Size: A A A
Published online

ABSTRACT

To the Editor::  —The review of the booklet on bacitracin which appears on page 424 of the September issue of the Archives of Internal Medicine has recently been brought to my attention. I should like to point out some fallacies in that review.The reviewer says that there are "many statements in this book which are hardly warranted on the basis of present-day knowledge," but he has not pointed out one such statement. Those that he uses as illustrations are inaccurate. Contrary to what the reviewer has stated, the book covers fully all of the studies on the nephrotoxic element in bacitracin reported up to the time of publication. Furthermore, nowhere in the book is the statement made that bacitracin is the treatment of choice in amebiasis.Contrary to what the reviewer has stated, (1) nephrotoxicity was of minor importance in the last 250 cases reported; (2) the purity of

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 38

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs